ClinicalTrials.govpublic full text
Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)
gastrointestinal stromal tumor (gist), imatinib, protein kinase inhibitors, gastrointestinal stromal tumors, digestive system diseases, digestive system neoplasms, gastrointestinal diseases, gastrointestinal neoplasms, adjuvant, persist, persis-5, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870284
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.